249 related articles for article (PubMed ID: 22978757)
1. Cellular sources of dysregulated cytokines in relapsing-remitting multiple sclerosis.
Romme Christensen J; Börnsen L; Hesse D; Krakauer M; Sørensen PS; Søndergaard HB; Sellebjerg F
J Neuroinflammation; 2012 Sep; 9():215. PubMed ID: 22978757
[TBL] [Abstract][Full Text] [Related]
2. Identification of Suitable Reference Genes for Peripheral Blood Mononuclear Cell Subset Studies in Multiple Sclerosis.
Oturai DB; Søndergaard HB; Börnsen L; Sellebjerg F; Christensen JR
Scand J Immunol; 2016 Jan; 83(1):72-80. PubMed ID: 26395032
[TBL] [Abstract][Full Text] [Related]
3. The role of fractalkine (CX3CL1) in regulation of CD4(+) cell migration to the central nervous system in patients with relapsing-remitting multiple sclerosis.
Blauth K; Zhang X; Chopra M; Rogan S; Markovic-Plese S
Clin Immunol; 2015 Apr; 157(2):121-32. PubMed ID: 25596452
[TBL] [Abstract][Full Text] [Related]
4. T cells producing GM-CSF and IL-13 are enriched in the cerebrospinal fluid of relapsing MS patients.
Ghezzi L; Cantoni C; Cignarella F; Bollman B; Cross AH; Salter A; Galimberti D; Cella M; Piccio L
Mult Scler; 2020 Sep; 26(10):1172-1186. PubMed ID: 31237799
[TBL] [Abstract][Full Text] [Related]
5. Cytokine and immune cell profiling in the cerebrospinal fluid of patients with neuro-inflammatory diseases.
Lepennetier G; Hracsko Z; Unger M; Van Griensven M; Grummel V; Krumbholz M; Berthele A; Hemmer B; Kowarik MC
J Neuroinflammation; 2019 Nov; 16(1):219. PubMed ID: 31727097
[TBL] [Abstract][Full Text] [Related]
6. pSTAT1, pSTAT3, and T-bet expression in peripheral blood mononuclear cells from relapsing-remitting multiple sclerosis patients correlates with disease activity.
Frisullo G; Angelucci F; Caggiula M; Nociti V; Iorio R; Patanella AK; Sancricca C; Mirabella M; Tonali PA; Batocchi AP
J Neurosci Res; 2006 Oct; 84(5):1027-36. PubMed ID: 16865709
[TBL] [Abstract][Full Text] [Related]
7. Relationship between cerebrospinal fluid biomarkers of inflammation and tissue damage in primary progressive multiple sclerosis.
Talbot J; Højsgaard Chow H; Mahler M; Buhelt S; Holm Hansen R; Lundell H; Vinther-Jensen T; Hellem MNN; Nielsen JE; Siebner HR; von Essen MR; Sellebjerg F
Mult Scler Relat Disord; 2022 Dec; 68():104209. PubMed ID: 36257152
[TBL] [Abstract][Full Text] [Related]
8. Leptin and its soluble receptor in plasma of patients suffering from remitting-relapsing multiple sclerosis (MS) In vitro effects of leptin on type-1 and type-2 cytokine secretion by peripheral blood mononuclear cells, T-cells and monocytes of MS patients.
Chatzantoni K; Papathanassopoulos P; Gourzoulidou E; Mouzaki A
J Autoimmun; 2004 Sep; 23(2):169-77. PubMed ID: 15324935
[TBL] [Abstract][Full Text] [Related]
9. Discriminative expression of CD39 and CD73 in Cerebrospinal fluid of patients with Multiple Sclerosis and Neuro-Behçet's disease.
Bahrini K; Belghith M; Maghrebi O; Bekir J; Kchaou M; Jeridi C; Amouri R; Hentati F; Belal S; Ben Sassi S; Barbouche MR
Cytokine; 2020 Mar; 130():155054. PubMed ID: 32151963
[TBL] [Abstract][Full Text] [Related]
10. Relapses in multiple sclerosis are associated with increased CD8+ T-cell mediated cytotoxicity in CSF.
Malmeström C; Lycke J; Haghighi S; Andersen O; Carlsson L; Wadenvik H; Olsson B
J Neuroimmunol; 2008 May; 196(1-2):159-65. PubMed ID: 18396337
[TBL] [Abstract][Full Text] [Related]
11. The effects of natalizumab on inflammatory mediators in multiple sclerosis: prospects for treatment-sensitive biomarkers.
Khademi M; Bornsen L; Rafatnia F; Andersson M; Brundin L; Piehl F; Sellebjerg F; Olsson T
Eur J Neurol; 2009 Apr; 16(4):528-36. PubMed ID: 19220425
[TBL] [Abstract][Full Text] [Related]
12. Higher expression of IL-12Rβ2 is associated with lower risk of relapse in relapsing-remitting multiple sclerosis patients on interferon-β1b therapy during 3-year follow-up.
Milosevic E; Dujmovic I; Markovic M; Mesaros S; Rakocevic G; Drulovic J; Mostarica Stojkovic M; Popadic D
J Neuroimmunol; 2015 Oct; 287():64-70. PubMed ID: 26439963
[TBL] [Abstract][Full Text] [Related]
13. Monocyte-derived cytokines in multiple sclerosis.
Filion LG; Graziani-Bowering G; Matusevicius D; Freedman MS
Clin Exp Immunol; 2003 Feb; 131(2):324-34. PubMed ID: 12562396
[TBL] [Abstract][Full Text] [Related]
14. Gene expression analysis of relapsing-remitting, primary progressive and secondary progressive multiple sclerosis.
Ratzer R; Søndergaard HB; Christensen JR; Börnsen L; Borup R; Sørensen PS; Sellebjerg F
Mult Scler; 2013 Dec; 19(14):1841-8. PubMed ID: 24085340
[TBL] [Abstract][Full Text] [Related]
15. Increased Level of Caspase-1 in the Serum of Relapsing-remitting Multiple Sclerosis (RRMS) Patients.
Beheshti M; Salehi Z; Abolfazli R; Shirzad H; Izad M
Iran J Allergy Asthma Immunol; 2020 Oct; 19(5):534-538. PubMed ID: 33463121
[TBL] [Abstract][Full Text] [Related]
16. Impact of fingolimod on CD4+ T cell subset and cytokine profile of relapsing remitting multiple sclerosis patients.
Kürtüncü M; Yılmaz V; Akçay Hİ; Türkoğlu R; Altunrende B; Çınar SA; Ulusoy C; Gündüz T; İçöz S; Kasap M; Çalışkan Z; Ötünç G; Eraksoy M; Tüzün E
J Neuroimmunol; 2019 Dec; 337():577065. PubMed ID: 31526917
[TBL] [Abstract][Full Text] [Related]
17. Toll-like receptor (TLR)7 and TLR9 agonists enhance interferon (IFN) beta-1a's immunoregulatory effects on B cells in patients with relapsing-remitting multiple sclerosis (RRMS).
Tao Y; Zhang X; Markovic-Plese S
J Neuroimmunol; 2016 Sep; 298():181-8. PubMed ID: 27609294
[TBL] [Abstract][Full Text] [Related]
18. Tumor necrosis factor-alfa and interleukin-4 in cerbrospinal fluid and plasma in different clinical forms of multiple sclerosis.
Obradović D; Kataranovski M; Dincić E; Obradović S; Colić M
Vojnosanit Pregl; 2012 Feb; 69(2):151-6. PubMed ID: 22500369
[TBL] [Abstract][Full Text] [Related]
19. Monocyte-derived IL12, CD86 (B7-2) and CD40L expression in relapsing and progressive multiple sclerosis.
Filion LG; Matusevicius D; Graziani-Bowering GM; Kumar A; Freedman MS
Clin Immunol; 2003 Feb; 106(2):127-38. PubMed ID: 12672403
[TBL] [Abstract][Full Text] [Related]
20. Thymosin-α1 expands deficient IL-10-producing regulatory B cell subsets in relapsing-remitting multiple sclerosis patients.
Giacomini E; Rizzo F; Etna MP; Cruciani M; Mechelli R; Buscarinu MC; Pica F; D'Agostini C; Salvetti M; Coccia EM; Severa M
Mult Scler; 2018 Feb; 24(2):127-139. PubMed ID: 28273784
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
